Alzheimer Disease clinical trials

Explore recruiting alzheimer disease clinical trials.

Recruiting alzheimer disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Alzheimer Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Therapeutic evaluation of low-dose IL-2-based immunomodulatory approach in patients with early AD

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Allogeneic adipose tissue derived-stem cells in Alzheimer disease

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Cognitive brain circuits and the spread of tau in vivo in humans.

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

I5T-MC-AACI: Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

Netherlands, Czechia, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

I9X-MC-MTAE: Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer’s Disease

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer’s Disease (DIAD)

Ireland, Germany, Spain, Netherlands, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

Alzheimer Disease trials by city

Alzheimer Disease in Toronto Alzheimer Disease in Vancouver Alzheimer Disease in Montreal Alzheimer Disease in Calgary Alzheimer Disease in Edmonton Alzheimer Disease in Ottawa Alzheimer Disease in Winnipeg Alzheimer Disease in Quebec City Alzheimer Disease in Hamilton Alzheimer Disease in Kitchener Alzheimer Disease in London Alzheimer Disease in Halifax Alzheimer Disease in New York Alzheimer Disease in Los Angeles Alzheimer Disease in Chicago Alzheimer Disease in Houston

Alzheimer Disease clinical trials

Recruiting alzheimer disease studies right now

Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Far-Infrared Therapy for the Effect of Alzheimer Disease Dementia

The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Effects and Mechanisms of Temporal Interference Brain Stimulation on Memory Function in Preclinical Alzheimer's Disease

Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol

The Brain Health PRO Online Risk Factor Reduction Study to Prevent Dementia

Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease

Links Between Cognitive Deficits During Normal or Pathological Aging and Slow Waves Measured in EEG

Synbiotic Formula (SCV09) in Alzheimer's Disease Patients

Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)

Also recruiting in Europe

Therapeutic evaluation of low-dose IL-2-based immunomodulatory approach in patients with early AD

Allogeneic adipose tissue derived-stem cells in Alzheimer disease

Cognitive brain circuits and the spread of tau in vivo in humans.

I5T-MC-AACI: Assessment of Safety, Tolerability, and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease

I9X-MC-MTAE: Assessment of Safety, Tolerability, and Efficacy of LY3372689 in Early Symptomatic Alzheimer’s Disease

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer’s Disease (DIAD)

Alzheimer Disease trials by city

Other conditions